Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms.

Noam E KopmarTed GooleyNiall CurleyKathryn RussellCarole ShawKelda SchonhoffJohn LimAnna B HalpernRoland Bruno WalterBart L ScottJacob AppelbaumPaul C HendrieElihu H EsteyMary-Elizabeth M Percival

Published in: Leukemia & lymphoma (2023)

Keyphrases

high dose
acute myeloid leukemia
high grade
low dose
stem cell transplantation
acute lymphoblastic leukemia
low grade
bone marrow
dendritic cells
multiple myeloma
hodgkin lymphoma